These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31419495)

  • 21. Biotechnology and the treatment of addictive disorders: new opportunities.
    Elkashef A; Biswas J; Acri JB; Vocci F
    BioDrugs; 2007; 21(4):259-67. PubMed ID: 17628123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune to addiction: how immunotherapies can be used to combat methamphetamine addiction.
    Hossain MK; Hassanzadeganroudsari M; Kypreos E; Feehan J; Apostolopoulos V
    Expert Rev Vaccines; 2021 Jun; 20(6):707-715. PubMed ID: 33970739
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunotherapies for drug addictions].
    Montoya I
    Adicciones; 2008; 20(2):111-5. PubMed ID: 18551223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addictions. Can an anti-seizure drug assist recovery from cocaine and crystal meth addiction?
    TreatmentUpdate; 2005 Mar; 17(2):5-6. PubMed ID: 17228465
    [No Abstract]   [Full Text] [Related]  

  • 25. Current concepts in pharmacotherapy of substance abuse.
    Gottschalk PC; Jacobsen LK; Kosten TR
    Curr Psychiatry Rep; 1999 Dec; 1(2):172-8. PubMed ID: 11122921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Illicit Heroin and Methamphetamine Use among Methadone Maintenance Treatment Patients in Dehong Prefecture of Yunnan Province, China.
    Wang R; Ding Y; Bai H; Duan S; Ye R; Yang Y; Wang J; Tang R; Gao M; He N
    PLoS One; 2015; 10(7):e0133431. PubMed ID: 26196394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide (NO) signaling as a potential therapeutic modality against psychostimulants.
    Liddie S; Balda MA; Itzhak Y
    Curr Pharm Des; 2013; 19(40):7092-102. PubMed ID: 23574445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.
    Ago Y; Nakamura S; Baba A; Matsuda T
    J Pharmacol Sci; 2008 Jan; 106(1):15-21. PubMed ID: 18198473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-drug vaccines to treat substance abuse.
    Kinsey BM; Jackson DC; Orson FM
    Immunol Cell Biol; 2009; 87(4):309-14. PubMed ID: 19333250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians.
    Rawls SM; Cavallo F; Capasso A; Ding Z; Raffa RB
    Eur J Pharmacol; 2008 Apr; 584(2-3):278-84. PubMed ID: 18342307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of antibody-based immunotherapy for methamphetamine abuse: immunization, and virus-mediated gene transfer approaches.
    Chen YH; Chen CH
    Curr Gene Ther; 2013 Feb; 13(1):39-50. PubMed ID: 23157545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CNS metabolism in high-risk drug abuse, German version : Insights gained from
    Bodea SV
    Radiologe; 2017 Jun; 57(6):443-449. PubMed ID: 28516232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development.
    Negus SS; Banks ML
    Pharmacol Biochem Behav; 2018 Jan; 164():32-39. PubMed ID: 28442370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic vaccines for substance dependence.
    Kosten TR; Biegel D
    Expert Rev Vaccines; 2002 Oct; 1(3):363-71. PubMed ID: 12901575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A monoclonal antibody specific for 6-monoacetylmorphine reduces acute heroin effects in mice.
    Bogen IL; Boix F; Nerem E; Mørland J; Andersen JM
    J Pharmacol Exp Ther; 2014 Jun; 349(3):568-76. PubMed ID: 24700886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using hapten design to discover therapeutic monoclonal antibodies for treating methamphetamine abuse.
    Peterson EC; Gunnell M; Che Y; Goforth RL; Carroll FI; Henry R; Liu H; Owens SM
    J Pharmacol Exp Ther; 2007 Jul; 322(1):30-9. PubMed ID: 17452421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy.
    Dickerson TJ; Janda KD
    AAPS J; 2005 Oct; 7(3):E579-86. PubMed ID: 16353936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly-drug and marijuana use among adults who primarily used methamphetamine.
    Herbeck DM; Brecht ML; Lovinger K; Raihan A; Christou D; Sheaff P
    J Psychoactive Drugs; 2013; 45(2):132-40. PubMed ID: 23909001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin.
    Kish SJ; Kalasinsky KS; Furukawa Y; Guttman M; Ang L; Li L; Adams V; Reiber G; Anthony RA; Anderson W; Smialek J; DiStefano L
    Mol Psychiatry; 1999 Jan; 4(1):26-32. PubMed ID: 10089005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A potential role for N-acetylcysteine in the management of methamphetamine dependence.
    McKetin R; Dean OM; Baker AL; Carter G; Turner A; Kelly PJ; Berk M
    Drug Alcohol Rev; 2017 Mar; 36(2):153-159. PubMed ID: 27241765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.